Thomas Wiggans

Thomas Wiggans

Chairman bij ANNEXON, INC.

Vermogen: 106 250 $ op 29-02-2024

72 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Founder of Dermira, Inc., Thomas G.
Wiggans
is a businessperson who has been at the head of 11 different companies and presently holds the position of Chairman of Annexon, Inc., Executive Chairman of Follica, Inc., Chairman of Jasper Therapeutics, Inc. and Chairman at Annexon Biosciences, Inc. Thomas G.
Wiggans
is also Chairman of The Biotechnology Institute and on the board of 6 other companies.
In his past career Mr. Wiggans was Principal at Eli Lilly & Co. and Chairman & Chief Executive Officer for Dermira, Inc. (a subsidiary of Eli Lilly & Co.), President-US Pharmaceutical Operations at Ares-Serono Group, Chairman & Chief Executive Officer for Connetics Corp., Chairman & Chief Executive Officer for Peplin, Inc., Chairman of Excaliard Pharmaceuticals, Inc., Chairman & Chief Executive Officer of Pardes Biosciences, Inc. and President & Chief Operating Officer of CytoTherapuetics, Inc. Mr. Wiggans received an undergraduate degree from the University of Kansas and an MBA from Southern Methodist University.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
28-11-2023 5 000 ( 0.03% ) 106 250 $ 29-02-2024
08-06-2023 0 ( -.--% ) - $ 29-02-2024

Actieve functies van Thomas Wiggans

BedrijvenFunctieBegin
ANNEXON, INC. Chairman 05-02-2021
JASPER THERAPEUTICS, INC. Chairman 01-11-2023
Annexon Biosciences, Inc. Chairman -
Director/Board Member -
Chairman 14-01-2021
Director/Board Member -
Wiggans Living Trust Director/Board Member -
Kansas Association of Defense Counsel Director/Board Member 29-07-2009
The Hoover Institution Director/Board Member 29-07-2009
░░░ ░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ -
░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Alle actieve functies van Thomas Wiggans

Eerdere bekende functies van Thomas Wiggans

BedrijvenFunctieEinde
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Ervaring van Thomas Wiggans in detail bekijken

Opleiding van Thomas Wiggans

Southern Methodist University Masters Business Admin
University of Kansas Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Thomas Wiggans in detail bekijken

Connecties

100 +

Eerstegraads connecties

31

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven4
ELI LILLY AND COMPANY

Health Technology

SANGAMO THERAPEUTICS, INC.

Health Technology

ANNEXON, INC.

Health Technology

JASPER THERAPEUTICS, INC.

Finance

Bedrijven in privébezit25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

CytoTherapuetics, Inc.

Finance

Health Technology

Commercial Services

The Hoover Institution

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Kansas Association of Defense Counsel

Health Technology

Wiggans Living Trust

Health Technology

Annexon Biosciences, Inc.

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Thomas Wiggans